Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 09, 2016 3:10 AM ET

Food and Staples Retailing

Company Overview of Walgreens Specialty Pharmacy, LLC

Company Overview

Walgreens Specialty Pharmacy, LLC offers specialty pharmacy services in the United States and Puerto Rico. The company distributes specialty medications and supplies, including injectable medications and specialty biotech therapies that are used to treat chronic, life-threatening, or rare conditions, such as cancer, Crohn's disease, growth hormone disorders, multiple sclerosis, psoriasis, rheumatoid arthritis, and others. Its services include refill scheduling and coordination; assistance with complex administration methods; side-effects management; disease-specific educational materials; therapy adherence assistance; and 24-hour pharmacist availability. The company also offers infusion serv...

500 Noblestown Road

Suite 200

Carnegie, PA 15106

United States

Founded in 1998

Phone:

412-325-6600

Fax:

877-231-8302

Key Executives for Walgreens Specialty Pharmacy, LLC

Chief Technology Officer
Compensation as of Fiscal Year 2015.

Walgreens Specialty Pharmacy, LLC Key Developments

Pfizer Selects Walgreens Specialty Pharmacy to Dispense Ibrance

Walgreens has announced the availability of Ibrance through Walgreens Specialty Pharmacy for those requiring access to advanced, metastatic breast cancer therapy. Walgreens Specialty Pharmacy was selected by Pfizer as one of a group of pharmacies to dispense Ibrance, for use, in combination with letrozole, as initial endocrine-based therapy for postmenopausal women with ER+/HER2- advanced breast cancer. Walgreens Specialty Pharmacy also has access to letrozole, the required accompaniment drug. Working collaboratively with oncology providers, Walgreens Specialty Pharmacy delivers comprehensive patient care for those managing cancer therapies. Patients benefit from Walgreens access to limited distribution drugs, as well as a number of support services. These include help verifying insurance and identifying financial assistance options and supportive nutrition care through Walgreens infusion services capabilities. Ibrance is available at select Walgreens specialty, community and health system pharmacies.

Similar Private Companies By Industry

Company Name Region
R&C Berndt, Inc. United States
Donut Bank Inc United States
Systems Services of America, Inc. United States
The Grove, Inc. United States
Healthy Food Ingredients, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Walgreens Specialty Pharmacy, LLC, please visit www.walgreens.com/pharmacy/specialtypharmacy.jsp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.